DONALD MAHONEY, JR. to Mercaptopurine
This is a "connection" page, showing publications DONALD MAHONEY, JR. has written about Mercaptopurine.
Connection Strength
0.592
-
Does intravenous 6-mercaptopurine decrease salvage after relapse in childhood acute lymphoblastic leukemia? Pediatr Blood Cancer. 2006 May 01; 46(5):660-1.
Score: 0.254
-
Intensification with intermediate-dose intravenous methotrexate is effective therapy for children with lower-risk B-precursor acute lymphoblastic leukemia: A Pediatric Oncology Group study. J Clin Oncol. 2000 Mar; 18(6):1285-94.
Score: 0.166
-
Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study. Cancer. 1995 May 15; 75(10):2623-31.
Score: 0.119
-
Intermediate-dose intravenous methotrexate with intravenous mercaptopurine is superior to repetitive low-dose oral methotrexate with intravenous mercaptopurine for children with lower-risk B-lineage acute lymphoblastic leukemia: a Pediatric Oncology Group phase III trial. J Clin Oncol. 1998 Jan; 16(1):246-54.
Score: 0.036
-
A comparison of early intensive methotrexate/mercaptopurine with early intensive alternating combination chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group phase III randomized trial. Leukemia. 2001 Jul; 15(7):1038-45.
Score: 0.011
-
Intensive alternating drug pairs for treatment of high-risk childhood acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study. Cancer. 1993 May 01; 71(9):2854-61.
Score: 0.006